INR:0227. rummy gold 500 Towards beta cell replacement therapy for diabetes! An upgraded pluripotent stem cell differentiation protocol is released Detailed result ...
Minesweeper board Junshi Biosciences Signs R&D Collaboration and License Agreement with Oncology Drug Company REVITOPE FDA rejects new antibiotic Cont ...
Coins Of Ra - Hold 130 major products volume purchases to be implemented today Jiangsu pharmaceutical companies won $500 million in antidiabetic dru ...
20h
Shares of Spero Therapeutics, Inc. (NASDAQ:SPRO – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $1.28 and traded as low ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback